Cargando…
REV-ERB activation as a novel pharmacological approach for treating inflammatory pain
Pain is a complex problem affecting millions of people worldwide. The current therapies to reduce pain are limited as many treatment options inadequately address the causes of pain, lead to tolerance of the drug, or have adverse effects including abuse potential. While there are many causes of pain,...
Autores principales: | Makhija, Sangeet, Griffett, Joshua D., Veerakanellore, Giri Babu, Burris, Thomas P., Elgendy, Bahaa, Griffett, Kristine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154555/ https://www.ncbi.nlm.nih.gov/pubmed/37153791 http://dx.doi.org/10.3389/fphar.2023.1171931 |
Ejemplares similares
-
REV-ERB agonism improves liver pathology in a mouse model of NASH
por: Griffett, Kristine, et al.
Publicado: (2020) -
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
por: Murray, Meghan H., et al.
Publicado: (2022) -
Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
por: Griffett, Kristine, et al.
Publicado: (2023) -
REV-ERB is essential in cardiac fibroblasts homeostasis
por: Luo, Xiaokang, et al.
Publicado: (2022) -
Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation
por: Amador, Ariadna, et al.
Publicado: (2016)